Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BCG vaccination to enhance non-specific protection in older adults during the COVID-19 pandemic
2020-003904-15Phase 3Completed
- Sponsor
- University of Southern Denmark
- Start
- Aug 2020
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, randomised trial of bcg vaccine in coronavirus disease 2019 (COVID-19), acute infection and Airways Infection (2 arms), sponsored by University of Southern Denmark. Started Aug 2020; status: completed.
02
Drugs
bcg vaccine
03
Conditions
coronavirus disease 2019 (COVID-19)acute infectionAirways Infection
Beyond the preview
Go deeper on 2020-003904-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-003904-15.